Form 4: Ambarella Inc. Director Sells 1,500 Shares Under 10b5-1 Trading Plan

Christopher Paisley, a director at Ambarella Inc., sold 1,500 shares of company stock at $73.8 per share on December 26, 2024, under a pre-arranged trading plan.

Summary

• Christopher Paisley, a director of Ambarella Inc., executed a sale of 1,500 ordinary shares on December 26, 2024.
• The shares were sold at a price of $73.8 per share.
• This transaction was conducted under a pre-established Rule 10b5-1 trading plan adopted on June 13, 2024.
• Following the transaction, Mr. Paisley directly owns 40,781 ordinary shares.

Sentiment

Score: 5

Explanation: The document reports a routine insider transaction under a pre-arranged plan, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine disclosure of an insider transaction, which is common for publicly traded companies. The use of a 10b5-1 plan indicates the sale was pre-planned and not based on any recent material non-public information.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a common practice among corporate insiders to avoid accusations of insider trading, aligning with standard practices in the industry.
• The sale of 1,500 shares is a relatively small transaction for a director, and is not unusual in the context of insider trading activity.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the stock price given the small volume and pre-planned nature of the transaction.

Key Dates

Keywords

Ambarella Inc, insider trading, stock sale, Form 4, Rule 10b5-1, Christopher Paisley, director